MCM Final - Angiogenesis Flashcards
endothelial cells
single layer of cells that lines vessels
localizes immune system and response to ischemic environment
-important roles
where are vessels derived from? (cell type)
mesoderm
cells in vessels
endothelial cells, basal lamina, connective tissue and smooth muscle, and pericytes
basal membrane in blood vessels
ECM laid down for support and to create barrier
smooth muscle in vessel?
only larger ones, not capillaries
pericyte
extends processes that surround the capillary
vasculogenesis
during embryonic development
-primitive vascular network from endothelial and hemopoetic precursors
angiogenesis
vessel formation during adulthood
-growth by new vessels sprouting from existing ones
during pathology**
angioblast
endothelial cell precursor
VEG-F
released by mesenchymal cells causing vasculogenesis
neovascularization
aka angiogenesis
capillary sprout
originates from existing capillary cell
tip cell - at tip of sprout (not dividing)
stalk cell - follow tip cell, form hollow lumen (actively dividing)
continues growing until reaches another sprout or vessel
tip cell
does not divide
has filopodia
begins formation of capillary sprout (from existent endothelium cell)
responds to guidance signals (semaphorins, slits, netrins, ephrins)
stalk cells
follows the tip cell during angiogenesis
actively dividing
-forms a hollow lumen
EPCs
endothelial precursor cells
migrate from bone marrow
-express VEGFR-2 and VE-cadherin
not necessary for angiogenesis
in ischemic patients - increase in number of EPCs
Process of Angiogenesis
1 vasodilation
-nitric oxide (NO) and VEGF dilate the area
2 degradation
-proteolysis of basement membrane (MMPs)
3 migration
-of endothelial cells in direction of growth
-growth factors or inhibitors
4 proliferation
-of endothelial cells
5 maturation
-when make contact with another stalk cell or vessel
-laying down basement membrane, recruiting pericytes, and maybe smooth muscle cells
MMPs
matrix metalloproteinases
-cause the degradation of the vessel basement membrane during angiogenesis
plasminogen activator
VEGF-A
vascular endothelial growth factor
acts as paracrine ligand
diffuse and interacts with VEGFR-2 receptor
- downstream signaling pathway - tyrosine kinase receptor
VEGFR-2
ligand is VEGF-A
tyrosine kinase receptor
leads to EPC migration from bone marrow, increased vascular permeability, endothelial cell survival and proliferation/motility, upregulate express of pro-angiogenic proteins
pro-angiogenic proteins upregulated by VEGF-A?
plasminogen activator
collagenase
don’t worry about these too much - will learn later
what induces VEG-F?
hypoxic conditions
- tissue needs more oxygen - done through Hif1 - expressed due to lack of oxygen
Notch receptor in angiogenesis
juxtacrine signaling
receptor expressed in stalk cells
allows us to control excessive proliferation of endothelial
decreases cells responsiveness to VEGF
ligand is delta - expressed by the tip cells
delta (ligand)
secreted from tip cells in response to VEGF activation
bind the notch receptor on the stalk cells
- results in decreased responsive to VEGF - decrease in branching and proliferation of endothelial stalk cells
angiopoietins
Ang1 and Ang2 function in opposite ways
Ang1
latter steps during maturation of vessel during angiogenesis
recruits pericytes and smooth muscles
Ang2
antagonist of Ang1
binds same receptor and acts as an inhibitor
-continues to allow the endothelial cells and limits the maturation of the vessels during angiogenesis
PDGF
platelet-derived growth factor
secreted by the endothelial cells and platelet cells
PDGFR is the receptor (on pericytes and smooth muscle)
release after Ang1 signaling
bFGF
basic fibroblast growth factor
from endothelial cells and macrophages
secreted and stored in the ECM
-has affinity for heparin
causes induction of mitosis
bFGFR
receptor for bFGF
- expressed on endothelial cells, fibroblasts, smooth muscle cells, neurons - induces mitosis
TGF-beta
transforming growth factor
induces VEGF expression
-on fibroblasts and endothelium
MMPs
matrix metalloproteinases
contains zinc
diverse family of enzyme
any type of tissue remodeling
secreted as zymogens (inactive) - because they are dangerous
release induced by VEGF, inflammation or damage
integrin signaling during angiogenesis
transmembrane receptor integrin binds juxtacrine ligandes
- group together and form focal adhesion complexes - leads to intracellular signaling cascase
focal adhesion complexes
integrin bound to juxtacrine ligand during angiogenesis
thrombospondin-1
inhibitor of angiogenesis
upregulated by p53
functions in ending the process of angiogenesis
mutation in what protein can promote angiogenesis?
p53
Hif-1 alpha
induces the expression of VEGF
angiostatin
inhibitor of angiogenesis
internal fragment of plasminogen (in circulation)
- plasminogen degrades bc of MMPs - releasesfragment of angiostatin
inhibits endothelial cell migration and division
endostatin
inhibits angiogenesis
fragment of collagen released due to MMP activity
-inhibits VEGF signaling
platelets
fragmented portions of cells
protein sack that is released
14 promoters and 12 inhibitors
when reaches injured area or clot
- regulators released in sequence - pro-angiogenic and later anti-angiogenic sequence - help with the maturation process in tissue
down regulation of angiogenesis?
high levels of oxygen leads to degradation of Hif1
no VEGF - no angiogenesis
VHL (von hippel lindau) marks Hif1 for degradation
VHL
von hippel lindau
E3 ubiquitin ligase that marks Hif1 for degradation
Von Hippel Lindau Sydrome
mutation in VHL leads to nonfunctioning protein
- cannot degrade Hif1 - therefore, constitutively expression of VEGF
leads to hemangioblastoma - blood vessel dense tumor
hemangioblastoma
blood vessel dense tumor
result of von hippel lindau syndrome
non-neovascularized tumor
not clinically detectable (except surface lesion)
small size
slow growth
benign
neovascularized tumor
tumor has ability to control capillary growth
can secrete angiogenic proteins
-induce capillary sprout growth
two way paracrine exchange in tumors
tumor - angiogenic proteins
-vessel growth to tumor
endothelial - chemoattractants
-tumor migration to blood vessel
direct drugs inhibiting angiogenesis?
acting on the endothelial cells to inhibit their response
ex./ bevacizumab (avastin)
indirect drugs for angiogenesis?
inhibits tumor from secreting pro-angiogenic proteins
ex./ trastuzumab (herceptin)
Bevacizumab
aka avastin
direct drug for inhibiting tumor angiogenesis
anti-VEGF antibody
used in diabetic retinopathy treatment
diabetic retinopathy treatment?
use bevacizumab
-intravitreal injection that causes the inhibition in vascularization of the eye
Trastuzumab
(aka herceptin)
-indirect
breast cancer treatment
- Her-2/neu are tyrosine kinases that are overexpressed or mutated in breast cancer - ligand - not known - activation results in pro-angiogenic factor secretion
drug acts as antibody antagonist